Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant - Concepedia

Concepedia

Publication | Open Access

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant

DOI Full Paper Access

72

Citations

26

References

2019

Year

Robert R. Redfield, Stanley C. Jordan, Stéphan Busque, Flavio Vincenti, E. Steve Woodle, Niraj M. Desai, Elaine F. Reed, Simon Tremblay, Andrea A. Zachary, Ashley Vo,

American Journal of Transplantation

References

	Year	Citations

Page 1